Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 164.00
-10.40 (-5.96%)
Apr 1, 2025, 5:31 PM IDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 346.29 million as of April 1, 2025. Its market cap has decreased by -61.26% in one year.
Market Cap
346.29M
Enterprise Value
174.13M
Revenue
34.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
164.00
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 346.29M, an increase of 600.28%. That is a compound annual growth rate of 6.09%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 65.58B |
| Danel (Adir Yeoshua) | 2.20B |
| Kamada | 1.41B |
| Bait Bakfar | 960.19M |
| Novolog (Pharm-Up 1966) | 813.77M |
| Ilex Medical | 701.99M |
| BrainsWay | 637.11M |
| SofWave Medical | 564.43M |